ITIH3 and chronic inflammatory demyelinating polyradiculoneuropathy: Thus, ITIH3 serum levels in PASS-negative anti-AChR-Ab-positive MG patients were significantly elevated not only compared to PASS-positive patients of the same serogroup, but also compared to anti-MuSK-Ab-positive and seronegative MG, CMS, IIM, and CIDP patients.